Michael Winter
About Michael Winter
Michael Winter serves as the Associate Director of Platform Biology and Bioanalysis at CytomX Therapeutics, where he leads the development of Probody Therapeutics. He has extensive experience in oncology and immunotherapy, with a strong background in mass spectrometry and various therapeutic classes.
Current Role at CytomX Therapeutics
Michael Winter serves as the Associate Director of Platform Biology and Bioanalysis at CytomX Therapeutics. He has held this position since 2022. In this role, he leads the development of Probody Therapeutics, focusing on conditionally activated pro-drug biologics within the tumor microenvironment. His responsibilities also include engaging in intellectual property support and managing CRO projects.
Previous Positions at CytomX Therapeutics
Prior to his current role, Michael Winter worked at CytomX Therapeutics in various capacities. He was a Senior Scientist II in Platform Biology from 2020 to 2022 and a Senior Scientist I from 2018 to 2020. He also held the position of Scientist II in Platform Biology from 2017 to 2018. His tenure at CytomX Therapeutics spans five years, during which he contributed to multiple projects in the field of oncology.
Education and Expertise
Michael Winter earned a Bachelor of Arts degree in Chemistry (Honors) and Religion from Kalamazoo College, where he studied from 2002 to 2006. He then pursued a Ph.D. in Chemistry at the University of California, Berkeley, completing his studies from 2006 to 2011. He furthered his academic career as a Postdoctoral Fellow at the University of California, San Francisco, from 2012 to 2017. His expertise encompasses multiple therapeutic classes, including monoclonal antibodies, antibody drug conjugates, T cell bispecifics, and small molecule inhibitors.
Research Experience and Skills
Michael Winter has significant experience in mass spectrometry techniques, including LC-MS, LC-MS/MS, and proteomics. His comprehensive scientific skill set includes assay development, lead optimization, target discovery, and mechanism of action studies. He has engaged in research that supports advancements in oncology, immunotherapy, and infectious disease.
Background in Research Institutions
Before joining CytomX Therapeutics, Michael Winter worked at the University of California, Berkeley as a Graduate Student Researcher from 2006 to 2011. He also served as a Postdoctoral Fellow at the University of California, San Francisco from 2012 to 2017. His research background in these institutions has contributed to his expertise in platform biology and bioanalysis.